Hydrodynamics-based transfer of human apolipoprotein A-I gene into mice: Study of factors involving an efficacy and duration of the transferred gene expression in animals' liver

Molekulyarnaya Biologiya

Volumn 38, Issue 6, 2004, Pages 1076-1084

  Akifiev, B N ^a   Dizhe, E B ^a   Efremov, A M ^b   Mogilenko, D A ^a,b   Olejnikova, G N ^a   Lapikov, I A ^a,b   Zhdanova, O Yu ^a   Kidgotko, O V ^a   Orlov, S V ^a,b   Perevozchikov, A P ^a,b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; COMPLEMENTARY DNA; MESSENGER RNA; PRIMER DNA;

ARTICLE; CELL STRAIN HEPG2; CYTOMEGALOVIRUS; GENE ACTIVITY; GENE EXPRESSION; GENE TRANSFER; GENE VECTOR; GENETIC ANALYSIS; HEPATOMA CELL; HUMAN; HUMAN CELL; HYDRODYNAMICS; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY RNA SEQUENCE; ANIMAL; GENETICS; LIVER; METABOLISM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

ANIMALIA; HUMAN HERPESVIRUS 5;

ANIMALS; APOLIPOPROTEIN A-I; BASE SEQUENCE; DNA PRIMERS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HUMANS; LIVER; MICE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS);

EID: 21644478561     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nabel G.J. 2003. In: Human Gene Therapy: Current Opportunities and Future Trends. Eds Rubanyi G.M., Yla-Herttuala S. Berlin: Springer-Verlag, pp. 1-16.
2. Morral N., O'Neal W., Zhou H., Langston C., Beaduet A. 1997. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. Hum. Gene Ther. 8, 1275-1286.
3. O'Neal W.K., Zhou H., Morral N., Aguilar-Cordova A.E., Pestaner J., Langston C., Mull B., Wang Y., Beaudet A.L., Lee B. 1998. Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery. Hum. Gene Ther. 9, 1587-1598.
4. De Geest B., van Linthout S., Lox M., Collen D., Holvoet P. 2000. Sustained expression of human apolipoprotein A-I after adenoviral gene transfer in C57BL/6 mice: Role of apolipoprotein A-I promoter, apolipoprotein A-I introns and human apolipoprotein E enchancer. Hum. Gene Ther. 11, 101-112.
5. Liu F., Song Y.K., Liu D. 1999. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6, 1258-1266.
6. Zhang G., Budker V., Wolff J.A. 1999. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10, 1735-1737.
7. Rossmanith W., Chabikovsky M., Herkner K., Schulte-Hermann R. 2002. Cellular gene dose and kinetics of gene expression in mouse livers transfected by high-volume tail-vein injection of naked DNA. DNA Cell Biol. 21, 847-853.
8. Lecocq M., Andrianaivo F., Warnier M.-T., Wattiaux-DeConinck S., Wattiaux R., Jadot M. 2003. Uptake by mouse liver and intracellular fate of plasmid DNA after a rapid tail vein injection of a small or a large volume. J. Gene Med. 5, 142-156.
9. Zhang G., Budker V., Williams P., Subbotin V., Wolff J.A. 2001. Efficient expression of naked DNA delivered itraarterially to limb muscles of nonhuman primates. Hum. Gene Ther. 12, 427-438.
10. Ignatovich I.A., Dizhe E.B., Pavlotskaya A.V., Akifiev B.N., Burov S.V., Orlov S.V., Perevozchikov A.P. 2003. Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. J. Biol. Chem. 278, 42625-42636.
11. Januzzi J.L., Azrolan N., O'Connell A., Aalto-Setala K., Breslow J.L. 1992. Characterizaton of the mouse apolipoprotein Apoa-1/Apoc-3 gene locus: genomic, mRNA, and protein sequences with comparison to other species. Genomics. 14, 1081-1088.
12. Widom R.L., Ladias J.A., Kouidou S., Karathanasis S.K. 1991. Synergistic interactions between transcription factors control expression of the apolipoprotein AI gene in liver cells. Mol. Cell Biol. 11, 677-687.
13. Parker Ponder K., Dunbar R.P., Wilson D.R., Darlington G.J., Woo S.L.C. 1991. Evaluation of relative promoter strength in primary hepatocytes using optimized lipofection. Hum. Gene Ther. 2, 41-52.
14. Rettinger S.D., Kennedy S.C., Wu X., Saaylors R., Hafenrichter D.G., Wayne Flye M., Parker Ponder K. 1994. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc. Natl. Acad. Sci. USA. 91, 1460-1464.
15. Dudov K.P., Perry R.P. 1984. The gene family encoding the mouse ribosomal protein L32 contains a uniquely expressed intron-containing gene and an unmutated processed gene. Cell. 37, 457-468.
16. Kardassis D., Laccotripe M., Talianidis I., Zannis V. 1996. Transcriptional regulation of the genes involved in lipoprotein transport. Hypertension. 27, 980-1008.
17. Higuchi K., Law S.W., Hoeg J.M., Shumacher U., Meglin N., Brewer B. 1988. Tissue-specific expression of apolipoprotein A-I (ApoA-I) is regulated by the 5′-flanking region of the human ApoA-I gene. J. Biol. Chem. 34, 18530-18536.
18. De Geest B., van Linthout S., Collen D. 2001. Sustained expression of human apoA-I following adenoviral gene transfer in mice. Gene Ther. 8, 121-127.
19. Van Linthout S., Collen D., de Geest B. 2002. Effect of promoters and enhancers on expression, transgene DNA persistence, and hepatotoxicity after adenoviral gene transfer of human apolipoprotein A-I. Hum. Gene Ther. 13, 829-840.
20. Nott A., Meislin S.H., Moore H.J. 2003. A quantitative analysis of intron effects on mammalian gene expression. RNA. 9, 607-617.
21. Miao K., Thompson A.R., Loeb K., Ye X. 2001. Long-term and theraupeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. Mol. Ther. 3, 947-957.